KOD
NASDAQ
$40.87
Kodiak Sciences Inc (KOD)
Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing, and marketing therapies to treat retinal diseases in the United States and international markets. The company is headquartered in Palo Alto, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $62.67 (+53.34%)
Market Cap
$2.64B
Free Cash Flow Yield
-5.62%
Beta (5Y)
1.68
Price Chart
Valuation
Market Cap$2.64B
P/B24.14
Profitability
EBITDA-$217M
EPS-$4.04
Financial Health
Free Cash Flow Yield-5.62%
Growth & Risk
EPS 5Y CAGR+4.23%
FCF 5Y CAGR+7.12%
Beta (5Y)1.68
Sharpe Ratio2.08